Intrasense SA (ALINS) AI Stock Analysis

• Market Cap: €15.54M
• Dividend Yield: N/A
• Average Volume (3M): 121.47K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.34
• Revenue Growth: -32.04%
• EPS Growth: -19.23%
• Country: FR
• Employees: 76
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.07
• Shares Outstanding: 52,716,263
• 10 Day Avg. Volume: 279,561
• 30 Day Avg. Volume: 121,465
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €0.50
• Price Target Upside: 66.67% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 46 Neutral
• Price Target: €0.50 ▲(66.67% Upside)

Intrasense SA's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues, consistent losses, and a weak balance sheet. Technical analysis provides some neutral signals, but the valuation remains unattractive due to negative earnings and lack of dividend yield. The absence of earnings call data and corporate events does not alter the overall assessment.

Intrasense SA Business Overview & Revenue Model

Company Description

Intrasense SA (ALINS) is a French medical software company specializing in advanced imaging and data management solutions for the healthcare sector. The company focuses on developing innovative software applications that enhance the analysis and interpretation of medical images, particularly in fields such as radiology and oncology. Intrasense's core products include its Myrian platform, which offers tools for image processing, visualization, and integration of multimodal imaging data, thereby supporting healthcare professionals in making better-informed decisions.

How the Company Makes Money

Intrasense generates revenue primarily through the sale of its software solutions and services to healthcare institutions, such as hospitals and clinics. The company adopts a subscription-based model for its software, allowing clients to access updates and support over time. Additionally, Intrasense may earn revenue from licensing agreements, training services for healthcare professionals, and potential partnerships with medical device manufacturers or healthcare IT companies. These partnerships can enhance its product offerings and market reach, contributing to stable revenue growth.

Intrasense SA Financial Statement Overview

Summary

Intrasense SA is facing severe financial challenges, with declining revenues, negative profit margins, and a high debt-to-equity ratio. Negative operating and free cash flows further highlight operational inefficiencies and financial instability.

Income Statement

Intrasense SA has been experiencing declining revenue with a negative trend in profitability. The gross profit margin is negative, indicating cost of goods sold exceeds revenue. Net profit margin is also negative, reflecting consistent net losses. There is a concerning decline in revenue over the years, with significant operating losses as evidenced by negative EBIT and EBITDA margins.

Balance Sheet

The company's balance sheet shows a high debt-to-equity ratio, indicating reliance on debt financing. The equity ratio is low, reflecting potential financial instability. Return on equity is negative, indicating that shareholders are not seeing returns on their investment. These factors suggest financial vulnerability and limited equity to cover liabilities.

Cash Flow

Intrasense SA reports negative operating cash flow and free cash flow, highlighting cash burn and operational challenges. The company is not generating sufficient cash from operations to cover expenses, and free cash flow is declining, indicating worsening cash position over time. The operating cash flow to net income ratio is negative, suggesting poor cash earnings quality.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.25M	3.31M	3.79M	4.19M	3.44M
Gross Profit	-3.81M	-885.00K	-1.15M	-1.05M	-454.00K
EBITDA	-4.60M	-2.68M	-2.73M	-611.00K	-214.00K
Net Income	-5.66M	-3.58M	-3.42M	-1.20M	-704.00K
Balance Sheet
Total Assets	7.68M	10.45M	6.51M	8.77M	6.36M
Cash, Cash Equivalents and Short-Term Investments	930.00K	4.55M	1.41M	4.76M	2.59M
Total Debt	1.41M	1.49M	2.06M	1.93M	2.26M
Total Liabilities	6.03M	3.17M	4.50M	3.78M	4.21M
Stockholders Equity	1.65M	7.29M	2.01M	4.99M	2.15M
Cash Flow
Free Cash Flow	-5.94M	-4.97M	-3.48M	-1.50M	-1.08M
Operating Cash Flow	-3.73M	-3.05M	-2.00M	-948.00K	-481.00K
Investing Cash Flow	-2.21M	-1.93M	-1.49M	-555.00K	-551.00K
Financing Cash Flow	2.33M	8.10M	137.00K	3.66M	2.75M

Intrasense SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.30
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALINS, the sentiment is Positive. The current price of 0.3 is above the 20-day moving average (MA) of 0.29, above the 50-day MA of 0.29, and above the 200-day MA of 0.28, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 60.40 is Neutral, neither overbought nor oversold. The STOCH value of 23.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALINS.

Intrasense SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	54 Neutral	€4.19B	12.96	-41.26%	2.53%	14.43%	-26.74%
ALINS	46 Neutral	€15.54M	―	-126.47%	―	-32.04%	-19.23%
ALMDT	44 Neutral	€91.99M	―		―	3.25%	-2.07%
ALAMA	41 Neutral	€13.32M	―		―	-17.36%	8.61%